Pediatric quality of life enjoyment and satisfaction questionnaire (PQ-LES-Q): Reliability and validity

被引:112
作者
Endicott, J
Nee, J
Yang, RY
Wohlberg, C
机构
[1] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Unit 123, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA
[3] Pfizer, New York, NY USA
关键词
quality of life; validation studies; depression; antidepressive agents;
D O I
10.1097/01.chi.0000198590.38325.81
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 [发展与教育心理学];
摘要
Objective: The pediatric version of the Short Form of the Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q) was developed to aid in the assessment of an important aspect of life experience in children and adolescents. Method: The reliability and validity of the PQ-LES-Q was tested using data from a sample of 376 outpatient children (6-11 years old) and adolescents (12-17 years old) with major depressive disorder. Results: The internal consistency coefficients at screening, baseline, and endpoint were high (0.87, 0.90, 0.89, respectively) as was the 1-week test-retest intraclass correlation coefficient of reliability (0.78). The correlations of the PQ-LES-Q total score with concurrent measures of severity of illness were in the moderate range (e.g., Global Clinical Impression of Severity, -0.40; Children's Global Assessment Scale, 0.36; Children's Depression Rating Scale total score, -0.45), as were the correlations with measures of change between baseline and endpoint (e.g., Clinical Global Impression of Severity, -0.34; Children's Global Assessment Scale, 0.33; Children's Depression Rating Scale total score, -0.45). Conclusions: These findings support the use of the PQ-LES-Q as an additional measure of current clinical status and outcome because it taps dimensions that are not covered by the commonly used global severity of illness or symptomatic measures.
引用
收藏
页码:401 / 407
页数:7
相关论文
共 22 条
[1]
Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life [J].
Bondareff, W ;
Alpert, M ;
Friedhoff, AJ ;
Richter, EM ;
Clary, CM ;
Batzar, E .
AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (05) :729-736
[2]
Efficacy and safety of sertraline treatment of posttraumatic stress disorder - A randomized controlled trial [J].
Brady, K ;
Pearlstein, T ;
Asnis, GM ;
Baker, D ;
Rothbaum, B ;
Sikes, CR ;
Farfel, GM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (14) :1837-1844
[3]
CRONBACH LJ, 1951, PSYCHOMETRIKA, V16, P297, DOI DOI 10.1007/BF02310555
[4]
ENDICOTT J, 1993, PSYCHOPHARMACOL BULL, V29, P321
[5]
Guy W, 1976, ECDEU Assessment manual for psychopharmacology, DOI DOI 10.1037/E591322011-001
[6]
Huebner ES, 2004, PSYCHOL REP, V94, P351
[7]
HUEBNER ES, 1994, PSYCOL ASSESS, V6, P295
[8]
Schedule for Affective Disorders and Schizophrenia for School-Age Children Present and Lifetime version (K-SADS-PL): Initial reliability and validity data [J].
Kaufman, J ;
Birmaher, B ;
Brent, D ;
Rao, U ;
Flynn, C ;
Moreci, P ;
Williamson, D ;
Ryan, N .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1997, 36 (07) :980-988
[9]
A double-blind, placebo-controlled study comparing the effects of sertraline versus amitriptyline in the treatment of major depression [J].
Lydiard, RB ;
Stahl, SM ;
Hertzman, M ;
Harrison, WM .
JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 (11) :484-491
[10]
The multidimensional anxiety scale for children (MASC): Factor structure, reliability, and validity [J].
March, JS ;
Parker, JDA ;
Sullivan, K ;
Stallings, P ;
Conners, CK .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1997, 36 (04) :554-565